Gossamer Bio, Inc. Common Stock (GOSS) stock analysis and AI prediction
The company facts of Gossamer Bio, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Gossamer Bio, Inc. Common Stock
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $68.7 million
- Size
- Micro cap
- Employees
- 162
- Headquarters
- SAN DIEGO, CA
- Listed since
- Feb. 8, 2019
- Website
- gossamerbio.com
More Healthcare stocks
Other micro cap stocks
Keep going
GOSS questions
What is the AI prediction for GOSS stock?
Each market day our model rates Gossamer Bio, Inc. Common Stock (GOSS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the GOSS prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for GOSS?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see GOSS options?
The GOSS options page explains its calls, puts and Greeks. The full GOSS options chain, every strike and expiry, is in the OpPreds app.